Mathilda Mandel
Impact in
-
- Multiple Sclerosis Research Studies
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 9
- COVID-19 Clinical Research Studies 4
- Co-authors
- Anat Achiron (24 shared papers)Michael Gurevich (16 shared papers)Gad Lavie (15 shared papers)Sapir Dreyer-Alster (10 shared papers)Polina Sonis (11 shared papers)David Magalashvili (11 shared papers)Shlomo Flechter (7 shared papers)Mark Dolev (9 shared papers)
- Journals
- Acta Oncologica (3 papers)British Journal of Haematology (3 papers)Journal of Neuroimmunology (2 papers)Therapeutic Advances in Neurological Disorders (2 papers)PLoS ONE (2 papers)
- Partner nations
- IsraelUnited StatesPoland
In The Last Decade
Mathilda Mandel
55 papers receiving 1.3k citations
Mathilda Mandel's Hit Papers
Peers
Comparison fields: 5 of 114
- Pathology and Forensic Medicine 307
- Infectious Diseases 267
- Neurology 135
- Immunology 192
- Genetics 68
Countries citing papers authored by Mathilda Mandel
This map shows the geographic impact of Mathilda Mandel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilda Mandel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilda Mandel more than expected).
Fields of papers citing papers by Mathilda Mandel
This network shows the impact of papers produced by Mathilda Mandel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilda Mandel. The network helps show where Mathilda Mandel may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathilda Mandel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies Hit paper breakdown → | 2021 | 236 |
| 2 | 2004 | 118 | |
| 3 | 2006 | 91 | |
| 4 | Enhanced ubiquitinylation of heat shock protein 90 as a potential mechanism for mitotic cell death in cancer cells induced with hypericin. | 2003 | 68 |
| 5 | 2021 | 58 | |
| 6 | 2000 | 52 | |
| 7 | 2020 | 51 | |
| 8 | 2007 | 50 | |
| 9 | 2009 | 43 | |
| 10 | 2011 | 42 | |
| 11 | 2004 | 41 | |
| 12 | 2022 | 40 | |
| 13 | 2000 | 38 | |
| 14 | 2004 | 37 | |
| 15 | 1996 | 35 | |
| 16 | 2005 | 27 | |
| 17 | 2022 | 27 | |
| 18 | 2021 | 26 | |
| 19 | 1995 | 26 | |
| 20 | 1994 | 25 |
About Mathilda Mandel
Mathilda Mandel is a scholar working on Molecular Biology, Infectious Diseases, Pathology and Forensic Medicine, Immunology and Neurology, having authored 55 papers that have together received 1.4k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (9 papers), Multiple Sclerosis Research Studies (7 papers), Immunotherapy and Immune Responses (6 papers), Photodynamic Therapy Research Studies (4 papers), COVID-19 Clinical Research Studies (4 papers), Neuroblastoma Research and Treatments (3 papers), Erythrocyte Function and Pathophysiology (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (307 citations), Infectious Diseases (267 citations), Neurology (135 citations), Immunology (192 citations) and Genetics (68 citations). Mathilda Mandel has collaborated with scholars based in Israel, United States and Poland. Frequent co-authors include Anat Achiron, Michael Gurevich, Gad Lavie, Sapir Dreyer-Alster, Polina Sonis, David Magalashvili, Shlomo Flechter, Mark Dolev, Shay Menascu and Rina Falb. Their work appears in journals such as Acta Oncologica, British Journal of Haematology, Journal of Neuroimmunology, Therapeutic Advances in Neurological Disorders and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.